Home › Therapeutic areas › Metabolic › Type 2 Diabetes

Type 2 Diabetes (7 companies)

Companies with an active program in Type 2 Diabetes.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
BLTE Belite Bio MetabolicOphthalmology Rare 1 NDA Submitted $6.35B 6
BMEA Biomea Fusion MetabolicOncology 1 Phase 2 $35.5M 4
KURA Kura Oncology MetabolicOncology 1 Approved $688M 13
NAMS NewAmsterdam Pharma CardiovascularMetabolic+1 1 NDA Submitted $2.33B 6
GPCR Structure Therapeutics MetabolicRespiratory Rare 1 Phase 3 $3.90B 5
VKTX Viking Therapeutics MetabolicNeurology Rare 2 Phase 3 $3.43B 9
VTVT vTv Therapeutics HematologyMetabolic+1 Rare 2 Phase 3 $69.4M 9